InvestorsHub Logo
Followers 83
Posts 36200
Boards Moderated 0
Alias Born 03/09/2010

Re: SkyLimit2022 post# 545513

Wednesday, 12/07/2022 7:29:42 PM

Wednesday, December 07, 2022 7:29:42 PM

Post# of 700286


Three murcidencel studies producing significant clinical survival data!



OK THREE WOW
1. controversial design eca, chaned end point
2. interim results, no stats presented
3. trial underway for 12 years, end point 2024, phase 2 trial.


LOL

THEY HATE ME CAUSE THEY AINT ME

NAILED IT ON EVERY STOCK

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News